期刊文献+

碘普罗胺注射液和碘克沙醇注射液在数字减影血管造影中的应用分析 被引量:5

下载PDF
导出
摘要 目的探讨碘普罗胺注射液和碘克沙醇注射液在数字减影血管造影中的应用情况。方法采用回顾性分析的方法,分析300例患者在行数字减影血管造影中的影像学效果和毒性反应,依据造影剂的不同分为碘普罗胺注射液组150例和碘克沙醇注射液组150例。结果两组患者影像学质量评价优良率均较高,差异无统计学意义,两组患者均有较少的轻度毒性反应发生,差异无统计学意义(P>0.05)。结论碘普罗胺注射液和碘克沙醇注射液两种造影剂应用于数字减影血管造影,影像学效果明显,不良反应少。
作者 王达 严静雯
出处 《中国处方药》 2014年第10期87-87,共1页 Journal of China Prescription Drug
  • 相关文献

参考文献3

  • 1刘玉,陶晓峰.CT成像造影剂的研究进展[J].上海医药,2014,35(13):1-2. 被引量:5
  • 2张沥.比较等渗与低渗碘对比剂的肾毒性:随机对照试验的Meta分析.兰州大学学报,2012,3(1):45-93.
  • 3王利新,景在平.威视派克研究进展.中华现代临床医学杂志,2004,2(4):103-104.

二级参考文献13

  • 1Gavant ML, Ellis JV, Klesges LM, et al. Diagnostic efficacy of excretory urography with low-dose, nonionic contrast media [J]. Radiology, 1992, 182(3): 657-660.
  • 2Gharekhanloo F, Torabian S. Comparison of allergic adverse effects and contrast enhancement between iodixanol and iopromide [J]. Iran J Radiol, 2012, 9(2): 63-66.
  • 3Stacul F, Thomsen HS. Nonionic monomers and dimers [J]. Eur Radiol, 1996, 6(5): 756-761.
  • 4Yaniv G, Portnoy O, Simon D, et al. Revised protocol for whole-body CT for multi-trauma patients applying triphasic injection followed by a single-pass scan on a 64-MDCT [J]. Clin Radiol, 2013, 68(7): 668-675.
  • 5Aertsen M, Termote B, Souverijns G, et aL The critical role of CT angiography in the detection and therapy of lower gastro-intestinal bleeding [J]. JBR-BTR, 2013, 96(2): 78-80.
  • 6Verburg FA, Apitzsch J, Lensing C, et al. Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT [J]. Eur J Radiol, 2013, 82(12): 2348-2352.
  • 7Mrowietz C, Franke RP, Jung F. Influence of different radiographic contrast media on the echinocyte formation of human erythrocytes [J]. Clin Hemorheol Microcirc, 2012, 50(1-2): 35-47.
  • 8Seeliger E, Cantow K, Arakelyan K, et al. Low-dose nitrite alleviates early effects of an X-ray contrast medium on renal hemodynamics and oxygenation in rats [J]. Invest Radiol, 2014, 49(2): 70-77.
  • 9Sahani DV, Soulez G, Chen KM, et al. A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography [J]. Invest Radiol, 2007, 42(12): 856-861.
  • 10吕树铮.对比剂:让人类健康前景“清晰”显现[N].中国医学论坛报,2013-07-11(10).

共引文献4

同被引文献60

  • 1悦保仕.碘克沙醇在血管造影中应用的临床观察[J].医药论坛杂志,2005,26(6):61-61. 被引量:4
  • 2易著文,杨华彬.造影剂与肾损害[J].临床儿科杂志,2005,23(12):887-889. 被引量:3
  • 3骆金铠,于桂香.造影剂肾病的危险因素及护理预防[J].中华护理杂志,2007,42(6):546-548. 被引量:63
  • 4中国药典[S].二部.2010.
  • 5中国药品生物制品检定所.中国药品检验标准操作规程[M].北京:中国医药科技出版社,2005.287-297
  • 6Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines [J ] . Eur Radiol, 201 1 , 21 (12) :2527-2541.
  • 7Hiiussler MD. Safety and patient comfort with iodixanol: a postmarketing surveillance study in 9 515 patients undergoing diagnostic CT examinations [ J ]. Acta Radial, 2010,51 (8) :924-933.
  • 8Zhang BC, Hou L, Lv B, et al. Post-marketing surveillance study with iodixanol in 20 185 Chinese patients from routine clinical practices [ J ]. Br J Radiol, 2014,87 ( 1034 ) : 20130325.
  • 9Reddan D, Laville M, Garovic VD. Contrast-induced nephropathy and its prevention: what do we really know from evidence-based findings? [ J 1. J Nephrol, 2009,22(3) :333-351.
  • 10Toprak O. What is the best definition of contrast-induced nephropathy?[J]. Ren Fail,2007,29(3):387-388.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部